These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2691123)

  • 21. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
    Moller SE; Moller BM; Olesen M; Fjalland B
    Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose oral contraceptives and carbohydrate metabolism.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):348-53. PubMed ID: 2196807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives.
    Corssmit EP; Stouthard JM; Romijn JA; Endert E; Sauerwein HP
    Metabolism; 1994 Dec; 43(12):1503-8. PubMed ID: 7990703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
    Leis D; Botterman P; Ermler R; Maurer U
    Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
    Skouby SO; Andersen O; Saurbrey N; Kühl C
    J Clin Endocrinol Metab; 1987 Mar; 64(3):519-23. PubMed ID: 3102539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of desogestrel on carbohydrate metabolism.
    Shoupe D
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1041-7. PubMed ID: 8447358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
    Krentz AJ; Coles NH; Williams AC; Nattrass M
    Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.
    Luyckx AS; Gaspard UJ; Romus MA; Grigorescu F; De Meyts P; Lefèbvre PJ
    Fertil Steril; 1986 May; 45(5):635-42. PubMed ID: 2938985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
    Jandrain BJ; Humblet DM; Jaminet CB; Scheen AJ; Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):378-81. PubMed ID: 2142578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
    Scheen AJ; Jandrain BJ; Humblet DM; Jaminet CB; Gaspard UJ; Lefèbvre PJ
    Fertil Steril; 1993 Apr; 59(4):797-802. PubMed ID: 8458499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups.
    Gelding SV; Niththyananthan R; Chan SP; Skinner E; Robinson S; Gray IP; Mather H; Johnston DG
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):55-62. PubMed ID: 8306481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic response to intravenous infusion of porcine and semi-synthetic human insulin in insulin-dependent diabetic men.
    Hale PJ; Brimble A; Crase J; Nattrass M
    Diabete Metab; 1986 Apr; 12(2):74-8. PubMed ID: 3522299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
    Devenport MH; Crook D; Wynn V; Lees LJ
    Br J Clin Pharmacol; 1989 Jun; 27(6):851-9. PubMed ID: 2547410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.